Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Biomacromolecules
|
January 10, 2006
Bone morphogenetic protein-2 binds as multilayers to a collagen delivery matrix: an equilibrium thermodynamic analysis
Randy Morin, David Kaplan, Bernardo Perez-Ramirez
Biomaterials
|
January 11, 2011
Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies
Nicholas Guziewicz, Annie Best, Bernardo Perez-Ramirez, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
April 5, 2008
Guide to collagen characterization for biomaterial studies
Leah C Abraham, Erin Zuena, Bernardo Perez-Ramirez, et al.
Journal of Pharmaceutical Sciences
|
August 23, 2012
Mechanistic complexity of subvisible particle formation: links to protein aggregation are highly specific
B Robert Simler, Guodong Hui, Jennifer E Dahl, et al.
Angewandte Chemie (International Ed. in English)
|
October 8, 2014
Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy
Ming Wang, Shuo Sun, Caleb I Neufeld, et al.
Advanced Drug Delivery Reviews
|
October 22, 2011
Viscosity of concentrated therapeutic protein compositions
Jan Jezek, Martin Rides, Barry Derham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 17, 2019
Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention
Burcin Yavuz, Jessica L Morgan, Carolina Herrera, et al.
Biophysical Reviews
|
September 2, 2021
A tribute to Dr. Serge N. Timasheff, our mentor
Kirk Aune, James Lee, V Prakash, et al.
Journal of Pharmaceutical Sciences
|
April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy
Linda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
Vincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Biomacromolecules
|
January 10, 2006
Bone morphogenetic protein-2 binds as multilayers to a collagen delivery matrix: an equilibrium thermodynamic analysis
Randy Morin, David Kaplan, Bernardo Perez-Ramirez
Biomaterials
|
January 11, 2011
Lyophilized silk fibroin hydrogels for the sustained local delivery of therapeutic monoclonal antibodies
Nicholas Guziewicz, Annie Best, Bernardo Perez-Ramirez, et al.
Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|
April 5, 2008
Guide to collagen characterization for biomaterial studies
Leah C Abraham, Erin Zuena, Bernardo Perez-Ramirez, et al.
Journal of Pharmaceutical Sciences
|
August 23, 2012
Mechanistic complexity of subvisible particle formation: links to protein aggregation are highly specific
B Robert Simler, Guodong Hui, Jennifer E Dahl, et al.
Angewandte Chemie (International Ed. in English)
|
October 8, 2014
Reactive oxygen species-responsive protein modification and its intracellular delivery for targeted cancer therapy
Ming Wang, Shuo Sun, Caleb I Neufeld, et al.
Advanced Drug Delivery Reviews
|
October 22, 2011
Viscosity of concentrated therapeutic protein compositions
Jan Jezek, Martin Rides, Barry Derham, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
March 17, 2019
Sustained release silk fibroin discs: Antibody and protein delivery for HIV prevention
Burcin Yavuz, Jessica L Morgan, Carolina Herrera, et al.
Biophysical Reviews
|
September 2, 2021
A tribute to Dr. Serge N. Timasheff, our mentor
Kirk Aune, James Lee, V Prakash, et al.
Journal of Pharmaceutical Sciences
|
April 3, 2015
Subvisible (2-100 μm) Particle Analysis During Biotherapeutic Drug Product Development: Part 1, Considerations and Strategy
Linda O Narhi, Vincent Corvari, Dean C Ripple, et al.
Biologicals : Journal of the International Association of Biological Standardization
|
September 2, 2015
Subvisible (2-100 μm) particle analysis during biotherapeutic drug product development: Part 2, experience with the application of subvisible particle analysis
Vincent Corvari, Linda O Narhi, Thomas M Spitznagel, et al.
Page
of 1